• Es befinden sich keine Produkte im Warenkorb.

  • LOGIN

Literatur und weiterführende Links (FOOD 22-23)

Literaturliste

Adkins Y, Kelley DS. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem 2010;21:781-92.

Appel LJ, Miller ER, 3rd, Seidler AJ, Whelton PK. Does supplementation of diet with «fish oil» reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med. 1993; 153 : 1429–1438.

Balk, EM, Lichtenstein, AH, Chung, M, et al. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 2006; 189:19.

Bent S, Bertoglio K, Hendren RL. Omega-3 fatty acids for autistic spectrum disorder: a systematic review. J Autism Dev Disord. 2009;39:1145-54

Berr C, Akbaraly T, Arnaud J, Hininger I, Roussel AM, Barberger Gateau P. Increased selenium intake in elderly high fish consumers may account for health benefits previously ascribed to omega-3 fatty acids. J Nutr Health Aging. 2009; 13 (1): 14–18.

Billman, GE, Kang, JX, Leaf, A. Prevention of ischemia-induced cardiac sudden death by n-3 polyunsaturated fatty acids in dogs. Lipids 1997; 32:1161.

Boudrault C, Bazinet RP, Ma DW. Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer’s disease. J Nutr Biochem. 2009;20:1-10.

Bougnoux P, Hajjaji N, Maheo K, Couet C, Chevalier S. Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth. Prog Lipid Res. 2010;49:76-86.

Brouwer, IA, Katan, MB & Zock, PL. Dietary alpha-linolenic acid is associated with reduced risk of fatal heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr. 2004; 134:919–22.

Cederholm T, Palmblad J. Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia? Curr Opin Clin Nutr Metab Care. 2010;13:150-5.

Charnock, JS, McLennan, PL, Abeywardena, MY. Dietary modulation of lipid metabolism and mechanical performance of the heart. Mol Cell Biochem 1992; 116:19.

Chin, JP, Gust, AP, Nestel, PJ, Dart, AM. Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans. Hypertension 1993; 21:22.

Clarke R, Frost C, Collins R et al. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ 1997; 314: 112-7

Clarke SD. Polyunsaturated Fatty Acid Regulation of Gene Transcription: A Molecular Mechanism to Improve the Metabolic Syndrome. J Nutr 2001; 131: 1129-32.

de Deckere EAM. Possible beneficial effect of fish and fish n-3 polyunsaturated fatty acids in breast and colorectal cancer. Euro J Cancer Prev. 1999; 8:213–221.

Dietschy JM. Dietary fatty acids and the regulation of plasma low density lipoprotein cholesterol concentrations. J Nutr 1998; 128 (2 Suppl): 444S-8S.

Dyer, AR, Persky, V, Stamler, J, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980; 112:736.

European Food Safety Authority. Scientific Opinion: Labelling reference intake values for n-3 and n-6 polyunsaturated fatty acids. The EFSA Journal. 2009; 1176, 1–11.

Fedor D, Kelley DS. Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care. 2009;12:138-46.

Fedorova I, Hussein N, Baumann MH, Di Martino C, Salem N, Jr. An n-3 fatty acid deficiency impairs rat spatial learning in the Barnes maze. Behav Neurosci. 2009; 123:196–205.

Geleijnse, JM, Giltay, EJ, Grobbee, DE, et al. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 2002; 20:1493.

Ginsberg HN, Barr SL, Gilbert A et al. Reduction of plasma cholesterol levels in normal men on an American Heart Association Step 1 diet with added monounsaturated fat. New Engl J Med 1990; 322: 574-9.

Gleissman H, Johnsen JI, Kogner P. Omega-3 fatty acids in cancer, the protectors of good and the killers of evil? Exp Cell Res. 2010;316:1365-73.

Grimsgaard, S, Bønaa, KH, Hansen, JB, Myhre, ES. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr 1998; 68:52.

Harris WS, Kris-Etherton PM, Harris KA. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep. 2008; 10:503–509.

Harris WS, Mozaffarian D, Rimm E, et al. Omega-6 Fatty Acids and Risk for Cardiovascular Disease: A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. 2009

Harris WS. n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997; 65:1645S–1654S.

Harris, WS, Rambjør, GS, Windsor, SL, Diederich, D. n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am J Clin Nutr 1997; 65:459.

Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics. 2003; 111:e39–44.

Hooijmans CR, Kiliaan AJ. Fatty acids, lipid metabolism and Alzheimer pathology. Eur J Pharmacol. 2008; 585:176–196.

Hooper L, Thompson RL, Harrison RA, et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ. 2006; 332:752–760

Horvath A, Koletzko B, Szajewska H. Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Br J Nutr. 2007; 98:253–259.

Jouven, X, Zureik, M, Desnos, M, et al. Resting heart rate as a predictive risk factor for sudden death in middle-aged men. Cardiovasc Res 2001; 50:373.

Judge MP, Harel O, Lammi-Keefe CJ. Maternal consumption of a docosahexaenoic acid-containing functional food during pregnancy: benefit for infant performance on problem-solving but not on recognition memory tasks at age 9 mo. Am J Clin Nutr. 2007; 85:1572–1577.

Jump DB, Botolin D, Wang Y, Xu J, Demeure O, Christian B. Docosahexaenoic acid (DHA) and hepatic gene transcription. Chem Phys Lipids. 2008; 153(1):3–13.

Kang, JX, Leaf, A. Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids. Am J Clin Nutr 2000; 71:202S.

Kannel, WB, Kannel, C, Paffenbarger RS, Jr, Cupples, LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113:1489.

Kenny, D, Warltier, DC, Pleuss, JA, et al. Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men. Am J Cardiol 1992; 70:1347.

Khoo NK, Freeman BA. Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment. Curr Opin Pharmacol. 2010;10:179-84

Kraegen EW, Cooney GJ. Free fatty acids and skeletal muscle insulin resistance. Curr Opin Lipidol. 2008 ;19:235-41.

Kris-Etherton PM, Hecker KD, Binkoski AE. Polyunsaturated fatty acids and cardiovascular health. Nutr Rev 2004; 62:414–426.

Laaksonen DE, Nyyssonen K, Niskanen L, Rissanen TH, Salonen JT. Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch Intern Med. 2005; 165:193–199.

Labarthe F, Gélinas R, Des Rosiers C. Medium-chain fatty acids as metabolic therapy in cardiac disease. Cardiovasc Drugs Ther. 2008;22:97-106.

Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol. 2009;54:585-94.

Leaf, A, Kang, JX, Xiao, YF, Billman, GE. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003; 107:2646.

Lee JH, O’Keefe JH, Lavie CJ, Marchioli R, Harris WS. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc. 2008;83:324-32.

Lin J, Yang R, Tarr PT et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell 2005; 120: 261-73.

Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop. Circulation. 2007; 116:320–335.

Lopez-Huertas E. Health effects of oleic acid and long chain omega-3 fatty acids (EPA and DHA) enriched milks. A review of intervention studies. Pharmacol Res. 2010;61:200-7.

Loscalzo JJ, Fredman EM, Rud I et al. Unsaturated fatty acids enhance low density lipoprotein uptake and degradation by peripheral blood mononuclear cells. Arteriosclerosis 1987; 7: 450-5.

Mannini A. et al. Dietary n-3 polyunsaturated fatty acids enhance metastatic dissemination of murine T lymphoma cells. British Journal of Nutrition 2009 1–4.

Margioris AN. Fatty acids and postprandial inflammation. Curr Opin Clin Nutr Metab Care. 2009;12:129-37.

Masson S, Latini R, Tacconi M, Bernasconi R. Incorporation and washout of n-3 polyunsaturated fatty acids after diet supplementation in clinical studies. J Cardiovasc Med (Hagerstown). 2007; 8 Suppl 1: S4–10.

McKarney C, Everard M, N’Diaye T. Omega-3 fatty acids (from fish oils) for cystic fibrosis. Cochrane Database of Syst Rev. 2007,Oct 14:CD002201.

McLennan, PL. Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models. Lipids 2001; 36 Suppl:S111.

Montgomery P, Richardson AJ. Omega-3 fatty acids for bipolar disorder. Cochrane Database of Syst Rev. 2008, Issue 2. Art. No.: CD005169.

Morgan NG. Fatty acids and beta-cell toxicity. Curr Opin Clin Nutr Metab Care. 2009 ;12:117-22.

Mori, TA, Watts, GF, Burke, V, et al. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 2000; 102:1264.

Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation. 1993; 88 : 523–533.

Mozaffarian D, Aro A, Willett WC. Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr. 2009 May;63 Suppl 2:S5-21.

Mozaffarian D, Ascherio A, Hu FB, et al. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation. 2005; 111:157–164.

Mozaffarian D. Does alpha-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence. Altern Ther Health Med. 2005; 11:24–30.

Mozaffarian, D, Geelen, A, Brouwer, IA, et al. Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 2005; 112:1945.

Nagao K, Yanagita T. Medium-chain fatty acids: functional lipids for the prevention and treatment of the metabolic syndrome. Pharmacol Res. 2010;61:208-12.

Oh K, Hu FB, Manson JE, Stampfer MJ, Willett WC. Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses’ health study. Am J Epidemiol. 2005; 161:672–679.

O’Keefe JH, Jr, Abuissa, H, Sastre, A, et al. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol 2006; 97:1127.

Owen C, Rees AM, Parker G. The role of fatty acids in the development and treatment of mood disorders. Curr Opin Psychiatry. 2008 Jan;21:19-24.

Palatini, P, Thijs, L, Staessen, JA, et al. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002; 162:2313.

Parkinson, AJ, Cruz, AL, Heyward, WL, et al. Elevated concentrations of plasma omega-3 polyunsaturated fatty acids among Alaskan Eskimos. Am J Clin Nutr 1994; 59:384.

Peet M. Omega-3 polyunsaturated fatty acids in the treatment of schizophrenia. Isr J Psychiatry Relat Sci. 2008;45:19-25.

Peoples, GE, McLennan, PL, Howe, PR, Groeller, H. Fish oil reduces heart rate and oxygen consumption during exercise. J Cardiovasc Pharmacol 2008; 52:540.

Petersen OH, Tepikin AV, Gerasimenko JV, Gerasimenko OV, Sutton R, Criddle DN. Fatty acids, alcohol and fatty acid ethyl esters: toxic Ca2+ signal generation and pancreatitis. Cell Calcium. 2009;45:634-42.

Pettersson EE, Rekola S, Berglund L, et al. Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: a prospective, double-blind, randomized study. Clin Nephrol 1994;41(4):183-90.

Pivik R. T. et al. Early infant diet and omega-3 fatty acid DHA: effects on resting cardiovascular activity and behavioral development during the first half-year of life. Dev Neuropsychol. 2009; 34:139-158.

Quinn J. F. et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease. JAMA. 2010; 304:1903-1911.

Raitt, MH, Connor, WE, Morris, C, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 2005; 293:2884.

Raz R, Gabis L. Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review. Dev Med Child Neurol. 2009 Aug;51:580-92.

Rett BS, Whelan J. Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: a systematic review. Nutr Metab (Lond). 2011; 8:36.

Riediger ND, Othman RA, Suh M, Moghadasian MH. A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc. 2009 Apr;109:668-79.

Russo GL. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol. 2009 Mar 15;77:937-46.

Sakamoto T, Cansev M, Wurtman RJ. Oral supplementation with docosahexaenoic acid and uridine-5′-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res. 2007; 1182:50-59.

Saravanan P, Davidson NC, Schmidt EB, Calder PC. Cardiovascular effects of marine omega-3 fatty acids. Lancet 2010;14;376:540-50.

Sarrazin, JF, Comeau, G, Daleau, P, et al. Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs. J Am Coll Cardiol 2007; 50:1505.

Schönfeld P, Wojtczak L. Fatty acids as modulators of the cellular production of reactive oxygen species. Free Radic Biol Med. 2008 Aug 1;45:231-41.

Serini S, Piccioni E, Merendino N, Calviello G. Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer. Apoptosis. 2009 Feb;14:135-52.

Shaper, AG, Wannamethee, G, Macfarlane, PW, Walker, M. Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. Br Heart J 1993; 70:49.

Simmer K. et al. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev: CD000375, 2008.

Simon J. A. et al. The relation of alpha-linolenic acid to the risk of prostate cancer: a systematic review and meta-analysis. Am J Clin Nutr. 2009; 89:1558S–1564S.

Simopoulos AP. The omega-6/omega-3 fatty acid ratio, genetic variation, and cardiovascular disease. Asia Pac J Clin Nutr. 2008;17 Suppl 1: 131–134.

Singer P, Shapiro H, Theilla M, Anbar R, Singer J, Cohen J. Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med. 2008 Sep;34:1580-92.

Smith BK, Robinson LE, Nam R, Ma DW. Trans-fatty acids and cancer: a mini-review. Br J Nutr. 2009 Nov;102:1254-66.

Smuts CM, Huang M, Mundy D, Plasse T, Major S, Carlson SE. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol. 2003; 101:469–479.

Suter P. Checkliste Ernährung: Thieme; 2005.

Szajewska H, Horvath A, Koletzko B. Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2006; 83:1337–1344.

Tabaka M. The effects of polyunsaturated fatty acids on coronary disease. JAAPA. 2008;21:39-40, 42-4.

Tai CC, Ding ST. N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention. J Nutr Biochem. 2010;21:357-63.

Takeuchi H, Sekine S, Kojima K, Aoyama T. The application of medium-chain fatty acids: edible oil with a suppressing effect on body fat accumulation. Asia Pac J Clin Nutr. 2008;17 Suppl 1:320-3.

Tanaka K, Ishikawa Y, Yokoyama M, et al. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke. 2008; 39:2052–2058.

Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008; 372: 1223–1230.

Terry P, Lichtenstein P, Feychting M, Ahlbom A, Wolk A. Fatty fish consumption and risk of prostate cancer. Lancet. 2001; 357:1764–1766.

Thronburg JT, Rudel LL. How do polyunsaturated fatty acids lower lipids? Curr Opinion Lipidol 1992; 23: 17-21.

Tsai W-S, Nagawa H, Kaizaki S, Tsuruo T, Muto T. Inhibitory effects of n-3 polyunsaturated fatty acids on sigmoid colon cancer transformants. J Gastroenterol. 1998; 33:206–212.

Turner D, Steinhart AH, Griffiths AM. Omega-3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis. Cochrane Database of Syst Rev. 2008; Issue 3. Art. No.: CD006443.

Tuttle KR, Shuler LA, Packard DP, et al. Comparison of low-fat versus Mediterranean-style dietary intervention after first myocardial infarction (from The Heart Institute of Spokane Diet Intervention and Evaluation Trial). Am J Cardiol. 2008; 101:1523–1530.

Uauy R., Dangour AD. Fat and fatty acid requirements and recommendations for infants of 0-2 years and children of 2-18 years. Ann Nutr Metab. 2009; 55:76-96.

van de Rest O. et al. Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology. 2008; 71:430-8.

van Marum RJ. Current and future therapy in Alzheimer’s disease. Fundam Clin Pharmacol. 2008; 22:265–274.

Virtanen, JK, Mursu, J, Voutilainen, S, Tuomainen, TP. Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation 2009; 120:2315.

von Au, D, Brändle, M, Rupp, H, Jacob, R. Influence of a diet rich in fish oil on blood pressure, body weight and cardiac hypertrophy in spontaneously hypertensive rats. Eur J Appl Physiol Occup Physiol 1988; 58:97.

von Schacky C. Omega-3 fatty acids: antiarrhythmic, proarrhythmic or both? Curr Opin Clin Nutr Metab Care. 2008;11:94-9.

Vrablík M, Prusíková M, Snejdrlová M, Zlatohlávek L. Omega-3 fatty acids and cardiovascular disease risk: do we understand the relationship? Physiol Res. 2009;58:S19-26.

Wang C, Harris WS, Chung M, et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr. 2006; 84:5–17.

Wertz PW. Essential fatty acids and dietary stress. Toxicol Ind Health. 2009;25:279-83.

White B. Dietary fatty acids. Am Fam Physician. 2009; 15;80:345-50.

Wood LG, Scott HA, Garg ML, Gibson PG. Innate immune mechanisms linking non-esterified fatty acids and respiratory disease. Prog Lipid Res. 2009;48:27-43.

Yamagishi K, Nettleton JA, Folsom AR. Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2008; 156: 965–974.

Yokoyama M. et al. Effects of EPA on major coronary events in hypercholestemic patients:a randomized open labeled, blinded endpoint analysis. Lancet. 2007; 369:1090-1098.

Yurko-Mauro K. et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010; 6:456-464.

Kursübergreifende Literaturangaben zu Vitaminen und Spurenelementen

Biesalski HK, Biscoff SC, Puchstein C. Ernährungsmedizin. Nach dem neuen Curriculum Ernährungsmedizin der Bundesärztekammer. 4. Auflage. Georg Thieme Verlag, Stuttgart 2010

Bundesinstitut für gesundheitllichen Verbraucherschutz und Veterinärmedizin. Toxikologische und ernährungsphysiologische Aspekte der Verwendung von Mineralstoffen und Vitaminen in Lebensmitteln. Teil I: Mineralstoffe (einschließlich Spurenelemente). Vorschläge für Regelungen und Höchstmengen zum Schutz des Verbrauchers vor Überdosierung beim Verzehr von Nahrungsergänzungsmitteln (NEM) und angereicherten Lebensmitteln. Januar 2002

Cliniguía. Actualización de diagnóstico y terapéutica. EviScience Publicaciones 2011

Colastra J: Lamberts. Manual de Nutrición Ortomolecular. El manual de consulta imprescindible. SIE Consultants sl 2010

D-A-CH (2000) Deutsche Gesellschaft für Ernährung (DGE), Österreichische Gesellschaft für Ernährung (ÖGE), Schweizerische Gesellschaft für Ernährungsforschung (SGE), Schweizerische Vereinigung für Ernährung (SVE): Referenzwerte für die Nährstoffzufuhr. 1. Auflage, Umschau/Braus Verlag, Frankfurt am Main

Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung: Referenzwerte für die Nährstoffzufuhr. 1. Auflage, 5., korrigierter Nachdruck, Neuer Umschau Buchverlag, Neustadt an der Weinstraße, 2013.

Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung: Referenzwerte für die Nährstoffzufuhr. Verfügbar unter: https://www.dge.de/wissenschaft/referenzwerte/ (eingesehen am 28.06.2022)

Dietl H., Ohlenschläger G. (2003) Handbuch der Orthomolekularen Medizin. Karl F. Haug Verlag, Stuttgart

Domke A, Großklaus R, Niemann B, Przyrembel H, Richter K, Schmidt E, Weißenborn A, Wörner B, Ziegenhagen R: Verwendung von Mineralstoffen in Lebensmitteln. Toxikologische und ernährungsphysiologische Aspekte Teil II Bundesinstitut für Risikobewertung. Verfügbar unter: http://www.bfr.bund.de/cm/350/verwendung_von_mineralstoffen_in_lebensmitteln_bfr_wissenschaft_4_2004.pdf (eingesehen am 28.06.2022)

Einkaufs-und Ernährungsverhalten in Deutschland TNS-Emnid-Umfrage des Bundesministerium für Ernährung und Landwirtschaft, BMEL, (2014). Verfügbar unter: https://www.bmel.de/SharedDocs/Downloads/DE/_Ernaehrung/Lebensmittel-Kennzeichnung/TNS-Emnid-EinkaufsErnaehrungsVerhaltenInDeutschland.pdf?__blob=publicationFile&v=2 (eingesehen am 28.06.2022)

Europäische Richtlinie (2008/100/EG) vom 28. Oktober 2008 über die Nährwertkennzeichnung von Lebensmitteln hinsichtlich der empfohlenen Tagesdosen, der Umrechnungsfaktoren für den Energiewert und der Definitionen online verfügbar unter: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32008L0100:DE:HTML (eingesehen am 07.07.2021)

Europäische Empfehlungen: European Micronutrient Recommendations Aligned (EURRECA). Verfügbar unter: http://www.eufic.org/en/collaboration/article/european-micronutrient-recommendations-aligned (eingesehen am 28.06.2022)

Food and Nutrtition Information Center der US Regierung (DRI-Empfehlungen): Verfügbar unter: https://www.nal.usda.gov/fnic/dri-nutrient-reports (eingesehen am 28.06.2022)

Food Standards Agency (2002) Expert Group on Vitamins and Minerals. Review of Molybdenum

Food Standards Agency (2003) Safe Upper Levels for Vitamins and Minerals. Expert Group on Vitamins and Minerals, May 2003

Gröber U: Orthomolekulare Medizin. Ein Leitfaden für Apotheker und Ärzte. 3. Auflage. Wissenschaftliche Verlagsgesellschaft mbH Stuttgart 2008

Heppe F, Wigand M: Lexikon Diätetische Indikationen. Spezielle Ernährungstherapie und Ernährungsprävention. 4. Auflage. Springer 2002

Hernandez Ramos F: Antienvejecimiento con nutrición ortomolecular. Integral 2007

Institute of Medicine: Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. National Academy Press, Washington, 2001

Koula-Jenik H, Kraft M, Miko M, Schulz RJ: Leitfaden Ernährungsmedizin. Urban & Fischer 2006

Otten JJ, Pitzi-Hellwig J, Meyers L (Eds): Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. The National Academies Press, Washington DC 2006

Richtlinie der European Food Safety Authority, EFSA, mit dem Titel „Scientific Committee on Food, Scientific Panel on Dietetic Products, Nutrition and Allergies: tolerable Upper Intake Levels for Vitamins and minerals. February 2006“.

Subcommittee on the Tenth Edition of the RDAs, Food and Nutrition Board, Commission on Life Sciences, National Research Council: Recommended Dietary Allowances: 10th Edition. National Academy Press, Washington DC, 1989

Vollwertig essen und trinken nach den 10 Regeln der DGE verfügbar unter: http://www.dge.de/modules.php?name=Content&pa=showpage&pid=15 (eingesehen am 28.06.2022)

Pharmabrain Logo

European Union Trademark no. 006894216
US Patent and Trademark Office reg. no. 3,705,613
International Registration 1460744
All rights reserved.

Wir sind Pharmabrain.

Pharmabrain GmbH – Wir trainieren Ihren Erfolg
Gesundheitskommunikation, Teamentwicklung, Projektmanagement

Kontakt

Pharmabrain GmbH
Telefon: +49-30-28091515
E-Mail: support@pharmabrain.org

Research and Training Center

Schumannstr. 7b
D-10117 Berlin

Verwaltung

Schumannstr. 7a
D-10117 Berlin